dalteparin has been researched along with Epistaxis in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Epistaxis: Bleeding from the nose.
Excerpt | Relevance | Reference |
---|---|---|
"Surprisingly, the risk for recurrence was similar in the ACAP and control groups (15%, Pā>ā." | 1.62 | The Impact of Traditional Anticoagulants, Novel Anticoagulants, and Antiplatelets on Epistaxis. ( Levi, L; Sapir, E; Soudry, E; Yaniv, D; Zavdy, O, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Yaniv, D | 1 |
Zavdy, O | 1 |
Sapir, E | 1 |
Levi, L | 1 |
Soudry, E | 1 |
Ahuja, RB | 1 |
Bansal, P | 1 |
Pradhan, GS | 1 |
Subberwal, M | 1 |
1 trial available for dalteparin and Epistaxis
Article | Year |
---|---|
An analysis of deep vein thrombosis in burn patients (part II): A randomized and controlled study of thrombo-prophylaxis with low molecular weight heparin.
Topics: Adolescent; Adult; Body Surface Area; Burns; Disease Management; Enoxaparin; Epistaxis; Female; Fibr | 2016 |
1 other study available for dalteparin and Epistaxis
Article | Year |
---|---|
The Impact of Traditional Anticoagulants, Novel Anticoagulants, and Antiplatelets on Epistaxis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Case-Control Studies; Enoxapar | 2021 |